Brief: PLx Pharma Reports Q4 GAAP Loss Per Share Of $0.73
11/03/2022 12:37
March 11 (Reuters) - PLx Pharma Inc PLXP.O :
* REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS AND
PROVIDES
BUSINESS UPDATE
* Q4 ADJUSTED NON-GAAP LOSS PER SHARE $0.73
* Q4 SALES $1.6 MILLION
* Q4 GAAP LOSS PER SHARE $0.73
* Q4 EARNINGS PER SHARE VIEW $-0.71, REVENUE VIEW $2.0
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4M9QHY
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice